Geneva Partners, LLC Stryker Corp Transaction History

Geneva Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$236.63 - $276.44 $954,565 - $1.12 Million	-4,034 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$248.9 - $280.09 $322,076 - $362,436	1,294 Added 47.23%	4,034 $1.06 Million
Q2 2021 Aug 06, 2021	BUY	$242.95 - $267.0 $48,590 - $53,400	200 Added 7.87%	2,740 $712,000
Q1 2021 May 05, 2021	SELL	$221.01 - $248.82 $382,347 - $430,458	-1,730 Reduced 40.52%	2,540 $619,000
Q4 2020 Feb 01, 2021	BUY	$202.01 - $245.04 $862,582 - $1.05 Million	4,270 New	4,270 $1.05 Million
Q4 2019 Feb 04, 2020	SELL	$197.98 - $220.53 $195,010 - $217,222	-985 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$180.24 - $205.58 $1.45 Million - $1.65 Million	-8,045 Reduced 89.09%	985 $202,000
Q1 2019 May 10, 2019	BUY	$152.46 - $198.0 $1.38 Million - $1.79 Million	9,030 New	9,030 $1.78 Million

2,162

285M

1.13M

1.1M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $133B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.